Stephen Wax Email

Head Clinical Research . Neurogastrx

Current Roles

Employees:
18
Revenue:
$3.6M
About
Neurogastrx is a biopharmaceutical company developing therapies for gastrointestinal disorders. Our lead product is under development for the treatment of gastroparesis, a debilitating condition caused by abnormal gastric function and affecting hundreds of thousands of patients in the US.
Neurogastrx Address
600 Unicorn Park Dr
Woburn, MA
United States
Neurogastrx Email